BRISTOL-MYERS SQUIBB CO (1BMY.MI) Fundamental Analysis & Valuation

BIT:1BMY • US1101221083

Current stock price

50.65 EUR
-2.15 (-4.07%)
Last:

This 1BMY.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1BMY.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1BMY was profitable.
  • In the past year 1BMY had a positive cash flow from operations.
  • Of the past 5 years 1BMY 4 years were profitable.
  • In the past 5 years 1BMY always reported a positive cash flow from operatings.
1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCF1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • 1BMY has a better Return On Assets (7.83%) than 61.22% of its industry peers.
  • With an excellent Return On Equity value of 38.19%, 1BMY belongs to the best of the industry, outperforming 91.84% of the companies in the same industry.
  • The Return On Invested Capital of 1BMY (19.52%) is better than 81.63% of its industry peers.
  • 1BMY had an Average Return On Invested Capital over the past 3 years of 14.47%. This is in line with the industry average of 14.21%.
  • The last Return On Invested Capital (19.52%) for 1BMY is above the 3 year average (14.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROIC 19.52%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1BMY.MI Yearly ROA, ROE, ROIC1BMY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • With a decent Profit Margin value of 14.64%, 1BMY is doing good in the industry, outperforming 63.27% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1BMY has grown nicely.
  • 1BMY has a better Operating Margin (35.82%) than 89.80% of its industry peers.
  • 1BMY's Operating Margin has improved in the last couple of years.
  • The Gross Margin of 1BMY (72.63%) is comparable to the rest of the industry.
  • 1BMY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
1BMY.MI Yearly Profit, Operating, Gross Margins1BMY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

5

2. 1BMY.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
  • Compared to 1 year ago, 1BMY has more shares outstanding
  • Compared to 5 years ago, 1BMY has less shares outstanding
  • 1BMY has a better debt/assets ratio than last year.
1BMY.MI Yearly Shares Outstanding1BMY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
1BMY.MI Yearly Total Debt VS Total Assets1BMY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • 1BMY has an Altman-Z score of 2.52. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 1BMY's Altman-Z score of 2.52 is in line compared to the rest of the industry. 1BMY outperforms 46.94% of its industry peers.
  • 1BMY has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as 1BMY would need 3.51 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.51, 1BMY is in the better half of the industry, outperforming 65.31% of the companies in the same industry.
  • 1BMY has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of 1BMY (2.33) is worse than 77.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Altman-Z 2.52
ROIC/WACC2.18
WACC8.96%
1BMY.MI Yearly LT Debt VS Equity VS FCF1BMY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • 1BMY has a Current Ratio of 1.26. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • 1BMY has a Current ratio (1.26) which is in line with its industry peers.
  • A Quick Ratio of 1.14 indicates that 1BMY should not have too much problems paying its short term obligations.
  • 1BMY has a better Quick ratio (1.14) than 67.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.14
1BMY.MI Yearly Current Assets VS Current Liabilites1BMY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2

3. 1BMY.MI Growth Analysis

3.1 Past

  • 1BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 439.47%, which is quite impressive.
  • Measured over the past years, 1BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
  • Looking at the last year, 1BMY shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
  • 1BMY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.54% yearly.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%

3.2 Future

  • Based on estimates for the next years, 1BMY will show a decrease in Earnings Per Share. The EPS will decrease by -4.15% on average per year.
  • Based on estimates for the next years, 1BMY will show a decrease in Revenue. The Revenue will decrease by -5.54% on average per year.
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue Next Year-1.84%
Revenue Next 2Y-1.98%
Revenue Next 3Y-5.39%
Revenue Next 5Y-5.54%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1BMY.MI Yearly Revenue VS Estimates1BMY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
1BMY.MI Yearly EPS VS Estimates1BMY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

8

4. 1BMY.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1BMY is valuated reasonably with a Price/Earnings ratio of 9.63.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 89.80% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.77, 1BMY is valued rather cheaply.
  • A Price/Forward Earnings ratio of 9.36 indicates a reasonable valuation of 1BMY.
  • 1BMY's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BMY is cheaper than 83.67% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1BMY to the average of the S&P500 Index (21.75), we can say 1BMY is valued rather cheaply.
Industry RankSector Rank
PE 9.63
Fwd PE 9.36
1BMY.MI Price Earnings VS Forward Price Earnings1BMY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1BMY is valued cheaper than 85.71% of the companies in the same industry.
  • 1BMY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1BMY is cheaper than 95.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.4
EV/EBITDA 7.26
1BMY.MI Per share data1BMY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1BMY does not grow enough to justify the current Price/Earnings ratio.
  • 1BMY has an outstanding profitability rating, which may justify a higher PE ratio.
  • 1BMY's earnings are expected to decrease with -4.05% in the coming years. This may justify a cheaper valuation.
PEG (NY)3.24
PEG (5Y)N/A
EPS Next 2Y0.29%
EPS Next 3Y-4.05%

7

5. 1BMY.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.27%, 1BMY is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.96, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 81.63% of the companies listed in the same industry.
  • 1BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.27%

5.2 History

  • The dividend of 1BMY is nicely growing with an annual growth rate of 6.51%!
Dividend Growth(5Y)6.51%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 71.52% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
  • 1BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
1BMY.MI Yearly Income VS Free CF VS Dividend1BMY.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B
1BMY.MI Dividend Payout.1BMY.MI Dividend Payout, showing the Payout Ratio.1BMY.MI Dividend Payout.PayoutRetained Earnings

1BMY.MI Fundamentals: All Metrics, Ratios and Statistics

BRISTOL-MYERS SQUIBB CO

BIT:1BMY (4/20/2026, 7:00:00 PM)

50.65

-2.15 (-4.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength65.84
Industry Growth15.53
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners83.3%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap103.15B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target52.72 (4.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.27%
Yearly Dividend2.19
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)8.14%
PT rev (3m)16.41%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)6.63%
Revenue NY rev (3m)6.92%
Valuation
Industry RankSector Rank
PE 9.63
Fwd PE 9.36
P/S 2.5
P/FCF 9.4
P/OCF 8.53
P/B 6.53
P/tB N/A
EV/EBITDA 7.26
EPS(TTM)5.26
EY10.38%
EPS(NY)5.41
Fwd EY10.68%
FCF(TTM)5.39
FCFY10.64%
OCF(TTM)5.94
OCFY11.73%
SpS20.22
BVpS7.75
TBVpS-9.39
PEG (NY)3.24
PEG (5Y)N/A
Graham Number30.2889 (-40.2%)
Profitability
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROCE 25.91%
ROIC 19.52%
ROICexc 23.22%
ROICexgc 84.94%
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
FCFM 26.65%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Debt/EBITDA 2.03
Cap/Depr 32.69%
Cap/Sales 2.72%
Interest Coverage 8.22
Cash Conversion 66.54%
Profit Quality 182.1%
Current Ratio 1.26
Quick Ratio 1.14
Altman-Z 2.52
F-Score7
WACC8.96%
ROIC/WACC2.18
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.84%
Revenue Next 2Y-1.98%
Revenue Next 3Y-5.39%
Revenue Next 5Y-5.54%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.47%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%

BRISTOL-MYERS SQUIBB CO / 1BMY.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a fundamental rating of 6 / 10 to 1BMY.MI.


Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.


What is the profitability of 1BMY stock?

BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for 1BMY stock?

The Price/Earnings (PE) ratio for BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 9.63 and the Price/Book (PB) ratio is 6.53.


What is the financial health of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.